Nanophase Technologies Corporation

    Nanophase Technologies Corporation

    OOTC:NANX
    - -
    USD
    - -
    - -
    39.93P/E
    Nanophase Technologies Corporation
    OTC:NANX
    (OTC Markets)

    Recent

    price

    - -

    P/E

    ratio

    39.93

    div

    yld

    - -

    ROIC.AI

    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    USD
    0.3
    0.45
    0.46
    0.41
    0.34
    0.35
    0.36
    0.35
    0.4
    0.42
    0.34
    0.45
    0.65
    0.76
    0.75
    0.84
    0.86
    Revenue per Share
    -0.23
    -0.19
    -0.16
    -0.1
    -0.09
    -0.06
    -0.04
    -0.04
    -0.03
    -0.06
    -0.08
    0.03
    0.05
    -0.05
    -0.09
    0.07
    0.05
    Basic EPS, GAAP
    -0.18
    -0.08
    -0.14
    -0.03
    -0.03
    -0.05
    -0.02
    -0.01
    -0.04
    -0.04
    -0.1
    -0.08
    0.01
    -0.09
    -0.06
    -0.04
    -0.09
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -3.69
    -3.88
    -4.04
    -3.59
    -3.18
    -3.23
    -3.27
    -3.06
    -3.04
    -2.88
    -2.74
    -2.6
    -2.15
    -2.03
    -2.1
    -1.6
    -1.49
    Book Value per Share
    0.66
    0.49
    0.35
    0.31
    0.19
    0.14
    0.1
    0.09
    0.1
    0.04
    0.04
    0.07
    0.17
    0.12
    0.04
    0.24
    0.23
    Tangible Book Value per Share
    21
    21
    21
    24
    28
    28
    29
    31
    31
    34
    37
    38
    45
    49
    50
    62
    67
    Basic Weighted Avg Shares
    6
    9
    10
    10
    10
    10
    10
    11
    12
    14
    13
    17
    29
    37
    37
    52
    57
    Sales/Revenue/Turnover
    -84.03
    -43.34
    -34.85
    -23.8
    -25.97
    -17.33
    -11.42
    -11.76
    -6.19
    -14.25
    -22.35
    8.67
    8.68
    -6.05
    -9.51
    9.8
    7.49
    Operating Margin (%)
    1
    1
    1
    1
    1
    1
    1
    1
    - -
    - -
    - -
    - -
    - -
    1
    1
    1
    1
    Depreciation Expense
    -5
    -4
    -3
    -2
    -2
    -2
    -1
    -1
    -1
    -2
    -3
    1
    2
    -3
    -4
    4
    3
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1.57
    - -
    - -
    5.09
    6.22
    Effective Tax Rate (%)
    -77.36
    -43.1
    -34.85
    -23.84
    -25.84
    -17.38
    -11.56
    -11.9
    -6.33
    -14.66
    -24.03
    5.78
    7.87
    -7.03
    -11.77
    8.09
    5.99
    Profit Margin (%)
    9
    6
    5
    5
    4
    3
    2
    2
    3
    1
    1
    2
    4
    3
    1
    4
    3
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    3
    4
    13
    14
    15
    9
    9
    LT Debt
    14
    10
    7
    8
    5
    4
    3
    3
    3
    1
    2
    3
    7
    6
    2
    15
    15
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    17.73
    15.52
    - -
    - -
    18.59
    13.7
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -1.59
    -3.97
    - -
    - -
    -5.82
    -4.92
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    ST Debt
    7
    6
    14
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    9
    9
    9
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    70
    70
    70
    Market Capitalization
    93
    152
    137

    Working Capital

    USD

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    Total Current Assets
    30
    29
    36
    Cash, Cash Equivalents & STI
    3
    1
    2
    Accounts Receivable, Net
    9
    5
    9
    Inventories
    15
    20
    22
    Total Current Liabilities
    23
    26
    33
    Payables & Accruals
    10
    14
    14
    ST Debt
    7
    6
    14
    Deferred Revenue
    6
    6
    5

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    78.89%
    169.84%
    685.8%
    Free Cash Flow
    -101.47%
    -255.86%
    -15.37%
    Net Income, GAAP
    -19.41%
    -68.1%
    -196.47%
    Sales/Revenue/Turnover
    20.19%
    35.19%
    40.35%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    9
    12
    8
    8
    37
    2024
    10
    13
    17
    13
    52
    2025
    15
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.02
    0.01
    -0.03
    -0.04
    -0.09
    2024
    0.02
    0.02
    0.04
    -0.01
    0.07
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • globenewswire.com

      Solésence Announces Uplisting to Nasdaq

    • seekingalpha.com

      Nanophase Technologies Corp. (NANX) Q4 2024 Earnings Call Transcript

    • globenewswire.com

      Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results

    • globenewswire.com

      Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call

    • globenewswire.com

      SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Solesence, Inc. f/k/a Nanophase Technologies Corporation (OTCQB: NANX) and Encourages Current NANX Shareholders to Contact the Firm

    • globenewswire.com

      Solésence Wins Best Prestige Finished Formula at the 2025 Cosmetics & Toiletries Allē Awards, Marking Third Consecutive Win

    • globenewswire.com

      Solésence Launches New Investor Relations Website

    • globenewswire.com

      Nanophase Technologies Rebrands as Solésence, Elevating the Future of Skin Health

    • seekingalpha.com

      Nanophase Technologies: Continued Evidence Of A Sunny Forecast

    • seekingalpha.com

      Nanophase Technologies Corporation (NANX) Q3 2024 Earnings Call Transcript

    • globenewswire.com

      Nanophase Reports Record Third Quarter Revenue and Profit

    • globenewswire.com

      Nanophase Technologies Announces Third Quarter 2024 Financial Release and Conference Call Details

    • seekingalpha.com

      Nanophase Technologies: Explosive Growth And Appreciation

    • seekingalpha.com

      Nanophase Technologies Corporation (NANX) Q2 2024 Earnings Call Transcript

    • prnewswire.com

      SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Nanophase Technologies Corporation (OTC: NANX)

    • globenewswire.com

      Nanophase Reports Record Second Quarter Revenue and Profit

    • globenewswire.com

      Nanophase Technologies Announces Second Quarter 2024 Financial Release and Conference Call Details

    • globenewswire.com

      Solésence Beauty Science Wins Cosmopack North America Formulation Award for Third Year in a Row

    • globenewswire.com

      Solésence Beauty Science and other Chicago Innovation Awards Winners to Ring the Nasdaq Opening Bell

    • globenewswire.com

      Nanophase Reports Record First Quarter Results